摘要
目的 探讨血细胞分析中白细胞、红细胞、血红蛋白及血小板对肝硬化患者诊断的临床价值.方法 检测100例肝硬化失代偿患者组和100例肝硬化代偿组及100例正常对照组血细胞分析并进行统计分析.结果 肝硬化失代偿组血细胞分析中白细胞（WBC）、红细胞（RBC）、血红蛋白（HGB）及血小板（PLT）水平与对照组相比有统计学意义（P〈0.05）;肝硬化代偿组血细胞分析中RBC、HGB和PLT水平与对照组相比有统计学意义（P〈0.05）;肝硬化失代偿组与肝硬化代偿组在 RBC、HGB和PL T水平比较有统计学意义（P〈0.05）.结论 血细胞分析作为常规检查,有助于辅助诊断肝硬化并在肝硬化分期有一定的临床应用价值.
Objective To evaluate the diagnostic value of WBC,RBC,HGB and PLT in patients with cirrhosis.Methods The blood samples of 100 patients with cirrhosis in decompensated period,100 patients in compensated stage and 100 healthy volunteers were collected.Measured value of WBC,RBC,HGB and PLT of all samples were determined.Results The levels of WBC,RBC, HGB and PLT in patients with cirrhosis in decompensated stage had statistical significance with healty group （P〈0.05）,they were statistically significant between patients with cirrhosis in compensated stage and healty group （P〈0.05）in levels of RBC,HGB, PLT,the level of RBC,HGB and PLT in patients with cirrhosis in decompensated had statistical significance with in compensated period （P〈0.05）.Conclusion as a routine check,blood cell analysis had clinical application value in diagnose cirrhosis and had ap-plication value in cirrhosis of the liver stages.
出处
《检验医学与临床》
CAS
2017年第A02期125-126,共2页
Laboratory Medicine and Clinic
